Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Experts discuss potential benefits of raising HDL
• Patients on long-term warfarin should have option for INR home monitoring
• Additional catheter-directed thrombolysis benefited patients with DVT
• Aspirin associated with 40% reduced risk for unprovoked VTE recurrence in Warfasa study
• Bariatric surgery decreased CV risks among obese patients
• Benefits of statin therapy confirmed in large, long-term trial
• CE-MARC: CV magnetic resonance bested standard imaging technique for diagnosing CHD
• Coaching bystanders in CPR boosts chances for survival from cardiac arrest
• Deaths attributed to HF decreasing in Europe
• Echocardiographic evaluation in cancer patients undergoing chemotherapy focus of recommendation papers
• EVEREST II: Device reduced mitral regurgitation in patients at high risk for surgery
• FAME II clinical trial enrollment stopped after interim analysis showed benefit of FFR
• FDA: Improper use of imaging generator a likely cause of excess radiation exposure
• No cause for delaying hip fracture surgery found in patients receiving antiplatelet drugs
• Patients with STEMI have higher hospital readmission rates in US than other countries
• Pulmonary pressure a strong predictor of death in patients with HF
• Statin therapy reduced mortality in patients hospitalized with influenza
• Testing of blood glucose levels recommended for all patients upon noncritical hospitalization
• Usefulness of CTA varies widely based on patient population
• FDA OKs expanded use of endovascular graft to treat aortic tears
• FDA proposes draft guidelines intended to improve representation of women in clinical studies
• Alcohol, obesity identified as underlying causes of nonischemic sudden cardiac death
• Androgen deprivation therapy not associated with CV death
• ASSERT: Subclinical atrial tachyarrhythmias associated with increased risk for ischemic stroke, systemic embolism
• Diuretic improved life expectancy of patients with systolic hypertension
• FDA risk communication system yielded inconsistent results
• High-volume medical centers do better job managing complications associated with pediatric heart surgery
• Highly sensitive troponin I assay allowed earlier diagnosis of MI
• Hypertension, thyroid hormone levels linked in children
• Improvements needed in personal health record usability
• Internet-based intervention failed to improve patient care after MI
• LEADERS: Biodegradable polymer BES noninferior to durable polymer SES at 4 years
• More research needed to evaluate role of vitamin D in reducing CVD
• No association found between CYP2C19 genotype, CV events
• Phentermine/topiramate improved weight loss when added to lifestyle modifications
• Recovery phase of stress test revealed most common long QT syndrome type
• SCAAR: New-generation DES safer than older DES, BMS
• Statin use may raise risk for diabetes in postmenopausal women
• Aggressive treatment urged for pregnant women with iliofemoral DVT
• Artery disorder frequently undiagnosed in millions of women
• Experts await more data on dronedarone
• LateTIME: Despite safety, no benefit to bone marrow cell therapy weeks after MI
• New AF ablation consensus document previewed at symposium
• Novel procedure shows promising results as treatment for persistent AF